Thyroid function is essential in regulating metabolism, energy levels, and overall well-being, making it imperative to understand the various biomarkers used to assess thyroid health. One such biomarker, T3 uptake or T3 resin uptake (T3RU), offers valuable insights into thyroid function and can aid clinicians in diagnosing and managing thyroid disorders.
This article explores the intricacies of T3 uptake by reviewing its definition, clinical significance, and interpretation in the context of thyroid function testing.
By examining the science behind T3 uptake and its role in thyroid panels, we aim to provide readers with a deeper understanding of this important thyroid marker and its implications for overall health and wellness.
T3 uptake, also known as T3 resin uptake (T3RU), describes the binding capacity of thyroid hormone-binding proteins in the bloodstream, primarily thyroxine-binding globulin (TBG). It assesses the availability of binding sites for thyroid hormones, particularly thyroxine (T4), within the blood plasma.
Despite its name, T3 uptake does not directly measure the uptake of T3 by cells but instead evaluates the extent to which thyroid-binding proteins are saturated with thyroid hormones.
It has been used historically to understand whether a high or low T4 value is actually due to an alteration of T4 production vs. an alteration in availability of TBG.
The clinical significance of T3 uptake lies in its ability to provide insights into thyroid function and hormone levels. While T3 uptake itself does not directly measure thyroid hormone concentrations, it indirectly reflects changes in thyroid hormone-binding protein levels.
Low T3 uptake may suggest low levels of free thyroid hormones, indicating hypothyroidism or conditions affecting thyroid-binding proteins, while high T3 uptake may indicate elevated free thyroid hormones, suggesting hyperthyroidism.
A simple way to remember the clinical utility of T3 uptake is to remember that it has a direct relationship with the concentration of thyroxine, or T4, in the blood and an inverse relationship with the concentration of binding proteins, particularly thyroxine binding globulin, in the blood.
In overt hyperthyroidism, there is more T4 in the bloodstream so fewer binding sites on TBG will be available. This correlates with a higher T3 uptake level.
In overt hypothyroidism, or in situations of increased concentration of TBG in the blood, there will be less T4 available (hypothyroidism) or more binding sites on TBG will be available (in certain clinical settings), so the T3 uptake will be lower.
It is important to understand that variations in availability of thyroid binding proteins can cause a clinical appearance of hyper- or hypothyroidism in the setting of normal thyroid function. Certain medications or hormone therapies can increase or decrease the availability of TBG, and some patients may have a TBG deficiency (often diagnosed in newborns). [3.]
With the increasing availability of total and free T3 and T4 testing and binding protein assays, this test is used less frequently than it was historically.
A TBG deficiency is clinically significant because TBG is essential to maintain a stable pool of thyroid hormones in the bloodstream. Without TBG, research suggests that existing thyroid hormone levels would be depleted within a short period. [14.]
However, with TBG present, there is only a minimal decrease in thyroxine (T4) and triiodothyronine (T3) levels, demonstrating its role in preventing abrupt fluctuations in thyroid hormone levels.
Conversely, a decrease in TBG levels leads to an increase in free T4, which then inhibits thyroid-stimulating hormone (TSH) production. Consequently, total T4 production decreases, so serum free T4 levels return to normal. [6.]
The T3RU, or T3 Uptake, serves as an indirect assessment of thyroxine-binding globulin (TBG) binding capacity.
In this test, a T3 resin binder is mixed with a patient's serum, along with a small amount of radioactive iodine-labeled T3 (125I-T3). This is then incubated for a period of time to allow the 125I-T3 to distribute between the resin binder and serum binding sites available in the patient’s blood.
After incubation the serum is removed, and the remaining 125I-T3 activity on the resin binder is measured. The percentage of 125I-T3 retained on the resin binder, relative to the total 125I-T3 added, multiplied by 100, defines the T3RU.
Normal T3RU values typically range between 25 and 50%, although many labs report normal values between 25-39% for adults. [1., 4.]
Drugs that Increase TBG and Decrease T3 Uptake [11.]
Drugs that Decrease TBG and Increase T3 Uptake [11., 16.]
The T3 uptake test involves a simple blood draw, where a healthcare professional collects a sample of venous blood from the patient's arm. After the blood sample is collected, it is processed in a laboratory where the T3 uptake is measured using specialized assays.
Patients may be advised to inform their healthcare provider about any medications, supplements, or medical conditions they have, as certain factors can influence T3 uptake levels. Biotin is a commonly-used supplement that is well-known to alter thyroid function studies. [9.]
Patients usually do not need to fast before the test, and there are no dietary restrictions.
However, it is essential to follow any instructions provided by the healthcare provider regarding medication use or fasting if indicated.
Falling within the normal range for T3 uptake typically indicates adequate binding capacity of thyroid-binding proteins and balanced thyroid hormone levels.
In a healthy individual, the T3 uptake value reflects the proportion of available binding sites on thyroid-binding proteins occupied by thyroid hormones. Normal T3 uptake values vary between laboratories but generally fall between 25% and 50%, depending on the assay methodology and reference ranges used.
Common normal findings fall between the following ranges: [1., 2., 15.]
Male
0-11 months: 23-34%
1-3 years: 24-35%
4-6 years: 24-34%
7-11 years: 24-33%
12-15 years: 25-37%
16-18 years: 24-38%
>18 years: 24-39%
Female
0-11 months: 23-36%
1-3 years: 24-36%
4-6 years: 24-35%
7-11 years: 22-35%
12-15 years: 23-37%
16-18 years: 23-35%
>18 years: 24-39%
Because different labs may report different findings based on their results over time, it is important to consult your lab company for their reference ranges.
A low T3 uptake indicates an excess of free thyroid hormones causing saturation of thyroid-binding proteins, leading to reduced binding capacity.
It is essential to determine the cause of low T3 uptake as a primary thyroid illness, an extrathyroidal illness, or the side effect of certain drugs or medications.
Elevated T3 uptake levels indicate decreased thyroid hormone levels leading to increased binding capacity of thyroid-binding proteins.
It is essential to determine the cause of high T3 uptake as a primary thyroid illness, and extrathyroidal illness, or the side effect of certain drugs or medications.
Thyroid Hormone Replacement Therapy: Adjusting thyroid hormone medications such as levothyroxine to achieve optimal thyroid hormone levels may influence T3 uptake.
Estrogen Therapy: Estrogen-containing medications like oral contraceptives or oral hormone replacement therapy may increase thyroid-binding protein concentrations, potentially decreasing T3 uptake Pregnant women should have their thyroid function monitored throughout pregnancy and postpartum.
Lifestyle Modifications: Regular physical exercise, adequate sleep, and stress management techniques can help regulate thyroid function and hormone levels, potentially impacting T3 uptake. [8., 9., 10.]
Nutritional Support: Consuming a balanced diet rich in nutrients like protein, vitamins, and minerals supports optimal thyroid function, potentially affecting T3 uptake. [5.]
Avoiding Stimulants: Limiting consumption of stimulants like caffeine and nicotine may help regulate thyroid hormone levels and prevent excessive fluctuations that could influence T3 uptake. [7., 12., 17.]
Monitoring Medications: Being mindful of medications that can affect thyroid function and TBG availability such as glucocorticoids or heparin and working with healthcare providers to adjust dosages or find alternatives if necessary can impact T3 uptake.
Addressing Underlying Conditions: Treating underlying medical conditions that may affect thyroid function, such as liver or kidney disease, can help normalize T3 uptake levels.
Click here to review testing options and order a T3 Uptake test.
[1.] 001156: T3 Uptake | LabCorp. www.labcorp.com. https://www.labcorp.com/tests/001156/t-sub-3-sub-uptake
[2.] Burke MD. Thyroid function studies. Test strategies and interpretation of results. Postgrad Med. 1980 Dec;68(6):169-77. doi: 10.1080/00325481.1980.11715634. PMID: 6776511.
[3.] Chakravarthy V, Ejaz S. Thyroxine-Binding Globulin Deficiency. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544274/
[4.] Dunlap DB. Thyroid Function Tests. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 142. Available from: https://www.ncbi.nlm.nih.gov/books/NBK249/
[5.] Duntas LH. Nutrition and thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2023 Dec 1;30(6):324-329. doi: 10.1097/MED.0000000000000831. Epub 2023 Aug 13. PMID: 37578378.
[6.] Franklyn J, Shephard M. Evaluation of Thyroid Function in Health and Disease. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. MDText.com, Inc.; South Dartmouth (MA): Sep 21, 2000.
[7.] Gauthier BR, Sola-García A, Cáliz-Molina M, Lorenzo PI, Cobo-Vuilleumier N, Capilla-González V, et al. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19(11):e13260.
[8.] Hong H, Lee J. Thyroid-Stimulating Hormone as a Biomarker for Stress After Thyroid Surgery: A Prospective Cohort Study. Med Sci Monit. 2022 Nov 10;28:e937957. doi: 10.12659/MSM.937957. PMID: 36352753; PMCID: PMC9664770.
[9.] Katzman BM et al 2018 Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. Epub 2018 Jul 20. PMID: 30036510.
[10.] Klasson CL, Sadhir S, Pontzer H. Daily physical activity is negatively associated with thyroid hormone levels, inflammation, and immune system markers among men and women in the NHANES dataset. PLoS One. 2022 Jul 6;17(7):e0270221. doi: 10.1371/journal.pone.0270221. PMID: 35793317; PMCID: PMC9258892.
[11.] Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):745-62. doi: 10.1016/j.beem.2013.10.003. Epub 2013 Oct 17. PMID: 24275187; PMCID: PMC3857600.
[12.] Manolis AA, Manolis TA, Melita H, Manolis AS. Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call? Trends Cardiovasc Med. 2020;30(2):57-69.
[13.] Nazem MR, Bastanhagh E, Emami A, Hedayati M, Samimi S, Karami M. The relationship between thyroid function tests and sleep quality: cross-sectional study. Sleep Sci. 2021 Jul-Sep;14(3):196-200. doi: 10.5935/1984-0063.20200050. PMID: 35186196; PMCID: PMC8848531.
[14.] Refetoff S. Thyroid Hormone Serum Transport Proteins. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. MDText.com, Inc.; South Dartmouth (MA): Mar 10, 2023.
[15.] Soldin SJ, Cook J, Beatey J, et al. Pediatric reference ranges for thyroxine and tri-iodothyronine uptake. Clin Chem. 1992; 38:960.
[16.] Stockigt J, Lim CF. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. 2009;23(6):753-767. doi:https://doi.org/10.1016/j.beem.2009.06.004
[17.] Zheng J, Zhu X, XU Gui-qing, et al. Relationship between caffeine intake and thyroid function: results from NHANES 2007–2012. Nutrition Journal. 2023;22(1). doi:https://doi.org/10.1186/s12937-023-00866-5